Nanjing Leads Biolabs clarifies award grant to executive director is exempt connected transaction under HK rules

PUBT · 1d ago
Nanjing Leads Biolabs clarifies award grant to executive director is exempt connected transaction under HK rules
  • Nanjing Leads Biolabs issued a supplemental clarification on its July 1, 2026 award grant under the H Share Award Scheme.
  • The clarification states the award grant to executive director Zuo Honggang is a connected transaction under Hong Kong Listing Rules.
  • No new shares will be issued on vesting or settlement, with the grant treated as part of his remuneration package.
  • The transaction is exempt from reporting, announcement, and independent shareholder approval requirements under Rules 14A.73(6) and 14A.95.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanjing Leads Biolabs Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12271713), on August 04, 2026, and is solely responsible for the information contained therein.